ALK and extranodal nasal NK/T cell lymphoma: The 3-year OS and PFS of NKTCL, ALCL (ALK-), AITL, and PTCL-NOS decreased in the following order: 78.3% and 67.9%, 71.4% and 57.1%, 66.6% and 61.5%, and 52.0% and 27.2%, respectively.